Literature DB >> 8169385

Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus colds.

D Proud1, J M Gwaltney, J O Hendley, C A Dinarello, S Gillis, R P Schleimer.   

Abstract

The potential involvement of interleukin-1 (IL-1) in the pathogenesis of experimental rhinovirus colds was examined. Nasal lavages were recovered before and for 5 days after rhinovirus infection from 44 subjects, 22 of whom were randomized to receive prophylaxis with glucocorticoids, while the rest received placebo. Immunoreactive IL-1 beta was significantly increased in subjects who were infected and symptomatic compared with noninfected volunteers or subjects who were infected but asymptomatic. Concentrations of immunoreactive IL-1 beta correlated with levels of kinins and albumin in lavage fluids. Studies of IL-1 bioactivity established that most activity in lavages from infected subjects was IL-1 beta. Glucocorticoid prophylaxis did not inhibit IL-1 production, nor did it significantly affect the symptomatic response to infection or, in a subset of patients, neutrophil infiltration. These data are consistent with the hypothesis that IL-1 could contribute to the pathogenesis of rhinovirus infections.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8169385     DOI: 10.1093/infdis/169.5.1007

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  44 in total

1.  Human major group rhinoviruses downmodulate the accessory function of monocytes by inducing IL-10.

Authors:  J Stöckl; H Vetr; O Majdic; G Zlabinger; E Kuechler; W Knapp
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

2.  Rhinovirus specific IgE can be detected in human sera.

Authors:  Jonathan S Tam; William T Jackson; Desire Hunter; David Proud; Mitchell H Grayson
Journal:  J Allergy Clin Immunol       Date:  2013-08-30       Impact factor: 10.793

3.  Inhibition of human rhinovirus-induced cytokine production by AG7088, a human rhinovirus 3C protease inhibitor.

Authors:  L S Zalman; M A Brothers; P S Dragovich; R Zhou; T J Prins; S T Worland; A K Patick
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

4.  Self-Rated Health in Healthy Adults and Susceptibility to the Common Cold.

Authors:  Sheldon Cohen; Denise Janicki-Deverts; William J Doyle
Journal:  Psychosom Med       Date:  2015 Nov-Dec       Impact factor: 4.312

5.  Human monocytic cells direct the robust release of CXCL10 by bronchial epithelial cells during rhinovirus infection.

Authors:  N L Korpi-Steiner; S M Valkenaar; M E Bates; M D Evans; J E Gern; P J Bertics
Journal:  Clin Exp Allergy       Date:  2010-06-07       Impact factor: 5.018

Review 6.  Nasal cytokines as mediators of illness during the common cold.

Authors:  William J Doyle; David P Skoner; Deborah Gentile
Journal:  Curr Allergy Asthma Rep       Date:  2005-05       Impact factor: 4.806

7.  Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure.

Authors:  M C Subauste; D B Jacoby; S M Richards; D Proud
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

Review 8.  Association of rhinovirus infections with asthma.

Authors:  J E Gern; W W Busse
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

Review 9.  Understanding the mechanisms of viral induced asthma: new therapeutic directions.

Authors:  Nicole G Hansbro; Jay C Horvat; Peter A Wark; Philip M Hansbro
Journal:  Pharmacol Ther       Date:  2008-01-29       Impact factor: 12.310

10.  Viral upper respiratory tract infection and otitis media complication in young children.

Authors:  Tasnee Chonmaitree; Krystal Revai; James J Grady; Audra Clos; Janak A Patel; Sangeeta Nair; Jiang Fan; Kelly J Henrickson
Journal:  Clin Infect Dis       Date:  2008-03-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.